Zhi Ying Kang

Guangzhou Kunlun Investment Co. Ltd. is a company that provides investment services. The company is based in Guangzhou, China. The Chinese company was founded in 1997. The CEO is Yong Hui Wang.

Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China.

Guangzhou Boao Zongheng Network Technology Co., Ltd. engages in the provision of entrepreneurial resource-sharing platform focusing on intellectual property. It offers technology analysis, market research and analysis, intellectual property analysis, and project pitching and business matching services. The company was founded by Zi Qun Zheng, Xiao Dan Chen and Xu Hui Xie on July 30, 2013 and is headquartered in Guangzhou, China.

Gortune Investment Co., Ltd. provides investment services. Its business covers capital markets, real estate, and international investment. The company was founded on September 8, 2016 and is headquartered in Guangzhou, China.

Guangzhou Xiangxue Airport Cross Border Iot Co., Ltd. engages in the provision of supply chain management services. Its business scope includes supply chain management; warehousing agency services; warehousing consulting services; import and export of goods; air freight forwarding service; cargo inspection agency service; joint transportation agency service; cold storage lease service; nutritional health consulting services; human resources outsourcing; conference and exhibition services; enterprise self-owned capital investment; chemical product testing services; housing leasing; ticketing services; handling and transportation full service agents; and shipping agent. The company was founded on May 3, 2017 and is headquartered in Guangzhou, China.

Guangdong Xiangxue Pharmaceutical Co., Ltd. engages in the business of tablets, hard capsules, small volume injections, freeze-dried powder injections, and active pharmaceutical ingredient. The company was founded on September 6, 2011 and is headquartered in Heyuan, China.

Guangzhou Xiangxue Health Industry Equity Investment Management Co., Ltd. engages in the management of equity investment and equity investment fund. The company was founded on May 8, 2018 and is headquartered in Guangzhou, China.

Guangdong Xiangxue Precision Medical Technology Co., Ltd. engages in TCR-based therapies for cancer. It provides research and development services, including large scale GMP grade lentivirus production, target identification and lead optimization, efficacy validation and safety testing in cell lines and animal models, clinical trial development, and market entry planning. The company was founded on November 12, 2015 and is headquartered in Guangzhou, China.